JP Patent

JP2512303B2 — ２−オキサゾリン−４，５−ジオンのフエニルヒドラゾン誘導体

Assigned to Kureha Corp · Expires 1996-07-03 · 30y expired

What this patent protects

Patent listed against ixazomib-citrate.

Drugs covered by this patent

ixazomib-citrate (IXAZOMIB CITRATE)

Patent Metadata

Patent number: JP2512303B2
Jurisdiction: JP
Classification: —
Expires: 1996-07-03
Drug substance claim: No
Drug product claim: No
Assignee: Kureha Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.